TherapeuticsMD (TXMD) Current Deferred Tax Assets (2012 - 2014)

TherapeuticsMD has reported Current Deferred Tax Assets for 3 years, with the latest figure at $152478.0 in Q4 2014.

• For the quarter ending Q4 2014, Current Deferred Tax Assets fell 10.83% year-over-year to $152478.0; the trailing twelve-month figure through Dec 2014 stood at $152478.0 (down 10.83% YoY), and the FY2014 full-year result was $152478.0, down 10.83% from the prior year.
• Current Deferred Tax Assets for Q4 2014 stood at $152478.0, down from $170996.0 in the prior quarter.
• The five-year high for Current Deferred Tax Assets was $170996.0 in Q4 2013, with the low at $110471.0 in Q4 2012.
• Historically, Current Deferred Tax Assets has averaged $144648.3 across 3 years, with a median of $152478.0 in 2014.
• Annual changes were most pronounced in 2013 — Current Deferred Tax Assets jumped 54.79% — and 2014, when it fell 10.83%.
• TherapeuticsMD's Current Deferred Tax Assets stood at $110471.0 in 2012, then jumped by 54.79% to $170996.0 in 2013, then dropped by 10.83% to $152478.0 in 2014.
• The last three Current Deferred Tax Assets figures came in at $152478.0 (Q4 2014), $170996.0 (Q4 2013), and $110471.0 (Q4 2012), per Business Quant data.